NDC11 42227008301
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 42227-0083-01 | 42227-0083 |
| 42227-0083-1 | 42227-0083 |
| 42227-083-01 | 42227-083 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cinryze | HUMAN C1-ESTERASE INHIBITOR | Takeda Pharmaceuticals America, Inc. | d53a911f-070d-498a-8a61-baab72b9d0fe | 2025-11-28 | Warnings, Adverse reactions | 42227-083-01 42227-083 42227008301 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.